You are not currently logged in.
Access JSTOR through your library or other institution:
If You Use a Screen ReaderThis content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
One-Sample Multiple Testing Procedure for Phase II Clinical Trials
Thomas R. Fleming
Vol. 38, No. 1 (Mar., 1982), pp. 143-151
Published by: International Biometric Society
Stable URL: http://www.jstor.org/stable/2530297
Page Count: 9
You can always find the topics here!Topics: Sample size, Phase II clinical trials, Significance level, Biometrics, Experimentation, Medical treatment, Decision making, Gaussian distributions, Applied statistics, Clinical trials
Were these topics helpful?See something inaccurate? Let us know!
Select the topics that are inaccurate.
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Preview not available
Commonly, the central objective of Phase II clinical trials is the assessment of the antitumor 'therapeutic efficacy' of a specific treatment regimen. It is of interest to formulate test procedures which can be employed in these trials to decide whether or not this therapeutic efficacy warrants further investigation. For ethical reasons, these procedures should allow for early termination if initial results are extreme. In this paper, a one-sample multiple testing procedure is proposed which employs the standard single-stage test procedure at the last test, and which both allows for early termination and essentially preserves the size, power and simplicity of the single-stage procedure.
Biometrics © 1982 International Biometric Society